467 / 1778
Surgery alone
•
TLH-BSO
•
no lymphadenectomy, no RT
•
95% relapse-free survival
Poulsen 1996; Mariani 2000 / 2008; Eltabbakh 1997; Webb 2000; Sorbe et al, 2009
➢
No vaginal brachytherapy
:
Randomized trial, vaginal recurrence rate:
•
Vaginal brachytherapy: 0-2%
•
No additional therapy: 2-5%
Low risk endometrial cancer